Global Plasma Fractionation Market Overview 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Plasma fractionation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global plasma fractionation industry report, size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global plasma fractionation market size reached US$ 23.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.7 Billion by 2028, exhibiting a growth rate (CAGR) of 5.8% during 2023-2028.
Plasma fractionation is a specialized process in the field of biotechnology and medicine that involves separating blood plasma into its components or fractions. It is primarily carried out to isolate and purify valuable proteins and other substances found in plasma for various medical and therapeutic purposes. It results in the separation and isolation of various plasma components, including albumin, immunoglobulins, clotting factors, and other proteins. It is also important for research purposes, which allows scientists to study and develop treatments for various diseases and conditions.
Global Plasma Fractionation Market Trends and Drivers:
The surging prevalence of chronic diseases and medical conditions that require plasma-derived therapies, such as hemophilia, immune deficiencies, and autoimmune disorders, represents one of the primary factors driving the demand for plasma fractionation around the world. Moreover, the increasing aging population is catalyzing the demand for plasma fractionation, as older individuals often require medical interventions that rely on plasma-derived products. In addition, the rising awareness and early diagnosis of rare diseases and genetic disorders is favoring the growth of the market. Apart from this, the growing use of plasma-derived therapies in areas affected by conflicts and natural disasters is influencing the market positively. Furthermore, the shifting preferences towards precision medicine, where treatments are tailored to the genetic makeup of individuals, is fueling the need for specialized plasma-derived products produced through plasma fractionation. Along with this, stringent regulations and quality standards implemented by governing authorities of numerous countries to ensure the safety and efficacy of plasma-derived products are supporting the market growth. Besides this, significant advancements in plasma collection techniques, including plasmapheresis and automated collection systems, and extensive research and development (R&D) activities are propelling the growth of the market. Additionally, the increasing number of collaborations between countries and international organizations to facilitate the exchange of plasma-derived products and expertise is strengthening the growth of the market.
Global Plasma Fractionation Market 2023-2028 Analysis and Segmentation:
Top Key Players covered in this report are: ADMA Biologics, Bio Products Laboratory Ltd., Boccard, Grifols, S.A., Hemarus Therapeutics Limited, Intas Pharmaceuticals Limited, LFB S.A., Merck Group, Octapharma AG, PlasmaGen BioSciences Pvt. Ltd., SK Plasma Co. Ltd. and Virchow Biotech Private Limited
The report segmented the market on the basis of region, product, sector, application and end user.
Breakup by Product:
- Immunoglobulins
- Albumin
- Coagulation factor VIII
- Coagulation factor IX
Breakup by Sector:
- Private Sector
- Public Sector
Breakup by Application:
- Neurology
- Immunology
- Hematology
- Other Applications
Breakup by End User:
- Hospitals and Clinics
- Clinical Research Laboratories
- Academic Institutes
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Key highlights of the report:
- Market Performance (2017-2022)
- Market Outlook (2023- 2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
